Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

The prognostic role of comorbidity in salivary gland carcinoma.

Terhaard CH, van der Schroeff MP, van Schie K, Eerenstein SE, Lubsen H, Kaanders JH, Smeele LE, Burlage FR, van Den Ende PL, Baatenburg de Jong RJ.

Cancer. 2008 Oct 1;113(7):1572-9. doi: 10.1002/cncr.23771.

2.

Facial nerve function in carcinoma of the parotid gland.

Terhaard C, Lubsen H, Tan B, Merkx T, van der Laan B, Baatenburg de Jong R, Manni H, Knegt P.

Eur J Cancer. 2006 Nov;42(16):2744-50. Epub 2006 Sep 6. Erratum in: Eur J Cancer. 2007 Aug;43(12):1883. Baatenburg-de Jong, Rob [corrected to Baatenburg de Jong, Rob].

PMID:
16950616
3.

The role of radiotherapy in the treatment of malignant salivary gland tumors.

Terhaard CH, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, van Den Ende PL, Burlage F; Dutch Head and Neck Oncology Cooperative Group.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):103-11.

PMID:
15629600
4.

Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.

Terhaard CH, Lubsen H, Van der Tweel I, Hilgers FJ, Eijkenboom WM, Marres HA, Tjho-Heslinga RE, de Jong JM, Roodenburg JL; Dutch Head and Neck Oncology Cooperative Group.

Head Neck. 2004 Aug;26(8):681-92; discussion 692-3.

PMID:
15287035
5.

Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group database.

Vander Poorten VL, Hart AA, van der Laan BF, Baatenburg de Jong RJ, Manni JJ, Marres HA, Meeuwis CA, Lubsen H, Terhaard CH, Balm AJ.

Cancer. 2003 Mar 15;97(6):1453-63.

6.

Landmarks for parotid gland surgery.

de Ru JA, van Benthem PP, Bleys RL, Lubsen H, Hordijk GJ.

J Laryngol Otol. 2001 Feb;115(2):122-5.

PMID:
11320828
7.

[Annual chest X-ray in patients after treatment for laryngeal or oral cancer: only a limited number of second primary lung cancers detected].

Buwalda J, Zuur CL, Lubsen H, Tijssen JG, Koole R, Hordijk GJ.

Ned Tijdschr Geneeskd. 1999 Jul 17;143(29):1517-22. Dutch.

PMID:
10443275
8.

Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity.

Cloos J, Bongers V, Lubsen H, Tobi H, Braakhuis BJ, Snow GB.

Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):941-4.

9.

The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer.

Bongers V, Braakhuis BJ, Tobi H, Lubsen H, Snow GB.

Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):595-8.

10.

A nationwide study of the epidemiology, treatment and survival of oropharyngeal carcinoma in The Netherlands.

Mak-Kregar S, Hilgers FJ, Levendag PC, Manni JJ, Lubsen H, Roodenburg JL, van der Beek JM, van der Meij AG.

Eur Arch Otorhinolaryngol. 1995;252(3):133-8.

PMID:
7662345
11.

The value of twice yearly bronchoscopy in the work-up and follow-up of patients with laryngeal cancer.

Rachmat L, Vreeburg GC, de Vries N, Hordijk GJ, Lubsen H, Manni JJ, Snow GB.

Eur J Cancer. 1993;29A(8):1096-9.

PMID:
8518019
12.

Premalignant laryngeal lesions.

Lubsen H, Olde Kalter PH.

Acta Otorhinolaryngol Belg. 1992;46(2):117-26. Review.

PMID:
1605016
13.

Rhabdomyoblasts in olfactory neuroblastoma.

Slootweg PJ, Lubsen H.

Histopathology. 1991 Aug;19(2):182-4. No abstract available.

PMID:
1822978
14.

Spindle-cell carcinoma of the oral cavity and larynx. Immunohistochemical aspects.

Slootweg PJ, Roholl PJ, Müller H, Lubsen H.

J Craniomaxillofac Surg. 1989 Jul;17(5):234-6.

PMID:
2474578
15.

An inverted papilloma with intracranial extension.

van Olphen AF, Lubsen H, van 't Verlaat JW.

J Laryngol Otol. 1988 Jun;102(6):534-7.

PMID:
3397657
16.

Transsphenoidal microsurgery as primary treatment in 25 acromegalic patients: results and follow-up.

van't Verlaat JW, Nortier JW, Hendriks MJ, Bosma NJ, Graamans K, Lubsen H, Vasen HF, Thijssen JH, Croughs RJ.

Acta Endocrinol (Copenh). 1988 Feb;117(2):154-8.

PMID:
3381631
17.

[Hyperplasia of the squamous cell epithelium of the larynx; the importance of classification].

Olde Kalter P, Lubsen H, Delemarre JF, Meijer CJ, Snow GB.

Ned Tijdschr Geneeskd. 1987 Oct 3;131(40):1773-6. Dutch. No abstract available.

PMID:
3670484
18.

Squamous cell hyperplasia of the larynx (a clinical follow-up study).

Kalter PO, Lubsen H, Delemarre JF, Snow GB.

J Laryngol Otol. 1987 Jun;101(6):579-88.

PMID:
3598359
19.

Vocal cord paralysis and tumour length in staging postcricoid cancer.

Willatt DJ, Jackson SR, McCormick MS, Lubsen H, Michaels L, Stell PM.

Eur J Surg Oncol. 1987 Apr;13(2):131-7.

PMID:
3556594
20.

Clinical implications of laryngeal amyloidosis.

Graamans K, Lubsen H.

J Laryngol Otol. 1985 Jun;99(6):617-23.

PMID:
4009058
21.

Quantitative morphometry of squamous cell hyperplasia of the larynx.

Olde Kalter P, Lubsen H, Delemarre JF, Alons CL, Veldhuizen RW, Meyer CJ, Snow GB.

J Clin Pathol. 1985 May;38(5):489-95.

Supplemental Content

Loading ...
Support Center